Understand the source comparison
Comparative Analysis: DSIP vs Other Sleep Peptides
DSIP Delta-opioid receptor modulation + GABAergic potentiation 1–5 ng/kg body weight 60–90 minutes Slow-wave sleep (Stage 3 NREM) Best for deep sleep enhancement without REM suppression. Requires nanogram-level precision Epithalon Telomerase activation + pinea
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- DSIP
- Delta-opioid receptor modulation + GABAergic potentiation
- 1–5 ng/kg body weight
- 60–90 minutes
- Slow-wave sleep (Stage 3 NREM)
- Best for deep sleep enhancement without REM suppression. Requires nanogram-level precision
- Epithalon
- Telomerase activation + pineal gland support
- 5–10 mg per cycle (10 days)
- 7–14 days (cumulative)
- Circadian rhythm normalization
- Indirect sleep benefits through melatonin regulation. Not acute sleep induction
- Selank
- Anxiolytic via GABA modulation
- 300–600 mcg per dose
- 30–60 minutes
- Sleep onset latency reduction
- Reduces pre-sleep anxiety but does not deepen sleep architecture
- Thymalin
- Immune modulation + thymic peptide signaling
- 5–10 mg per cycle
- 5–10 days (cumulative)
- Indirect via reduced inflammatory sleep disruption
- Not a sleep peptide. Benefits emerge from reduced systemic inflammation interfering with sleep
- Cerebrolysin
- Neurotrophic factor activation
- 5–10 mL per dose (clinical)
- 3–7 days (cumulative)
- REM sleep quality improvement
- Primarily cognitive. REM improvements are secondary to neuroprotective effects
- DSIP stands alone in its acute, architecture-specific sleep effects at sub-microgram doses. Epithalon and Thymalin support sleep indirectly through circadian and immune optimization, but neither provides the rapid slow-wave enhancement DSIP delivers. Researchers targeting objective polysomnographic improvements in Stage 3 sleep within 7–10 days consistently select DSIP over alternatives.